BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33325075)

  • 21. Lung cancer control in the UK hit badly by COVID-19 pandemic.
    Gourd E
    Lancet Oncol; 2020 Dec; 21(12):1559. PubMed ID: 33189158
    [No Abstract]   [Full Text] [Related]  

  • 22. Cessation of cancer screening: An unseen cost of the COVID-19 pandemic?
    Tan KK; Lau J
    Eur J Surg Oncol; 2020 Nov; 46(11):2154-2155. PubMed ID: 32409112
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of COVID-19 pandemic on lung cancer treatment scheduling.
    Fujita K; Ito T; Saito Z; Kanai O; Nakatani K; Mio T
    Thorac Cancer; 2020 Oct; 11(10):2983-2986. PubMed ID: 32790028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia.
    Feletto E; Grogan P; Nickson C; Smith M; Canfell K
    Public Health Res Pract; 2020 Dec; 30(4):. PubMed ID: 33294902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the COVID-19 Pandemic on Volumes and Disparities in Lung Cancer Screening.
    Henderson LM; Benefield T; Bosemani T; Long JM; Rivera MP
    Chest; 2021 Jul; 160(1):379-382. PubMed ID: 33417898
    [No Abstract]   [Full Text] [Related]  

  • 26. Thoracic cancer surgery during the COVID-19 pandemic: a consensus statement from the Thoracic Domain of the Asian Society for Cardiovascular and Thoracic Surgery.
    Jheon S; Ahmed AD; Fang VW; Jung W; Khan AZ; Lee JM; Sihoe AD; Thongcharoen P; Tsuboi M; Turna A; Nakajima J
    Asian Cardiovasc Thorac Ann; 2020 Jul; 28(6):322-329. PubMed ID: 32609557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting early diagnosis and recovering from the COVID-19 pandemic in lung cancer through public awareness campaigns: learning from patient and public insight work.
    Evison M; Taylor S; Grundy S; Perkins A; Peake M
    BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34750168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should Lung Cancer Screening Be Suspended During a Pandemic?
    Gibney BC; Sade RM; Detterbeck FC; Wood DE
    Ann Thorac Surg; 2022 Jan; 113(1):9-12. PubMed ID: 34560045
    [No Abstract]   [Full Text] [Related]  

  • 29. Operational Challenges of a Low-Dose CT Lung Cancer Screening Program During the Coronavirus Disease 2019 Pandemic.
    Lang M; Yeung T; Shepard JO; Sharma A; Petranovic M; Flores EJ; McLoud TC; Som A; Saini S; Prabhakar AM; D Succi M; Little BP
    Chest; 2021 Mar; 159(3):1288-1291. PubMed ID: 33121979
    [No Abstract]   [Full Text] [Related]  

  • 30. Pre- and post-operative screening in limited-term elective cancer surgery patients during the COVID-19 pandemic.
    Zizzo M; Bollino R; Annessi V
    J Visc Surg; 2020 Jun; 157(3 Suppl 1):S69-S70. PubMed ID: 32381427
    [No Abstract]   [Full Text] [Related]  

  • 31. Lung cancer in the era of COVID-19: what can we expect?
    Araujo-Filho JAB; Normando PG; Melo MDT; Costa AN; Terra RM
    J Bras Pneumol; 2020 Oct; 46(6):e20200398. PubMed ID: 33111754
    [No Abstract]   [Full Text] [Related]  

  • 32. Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic.
    Guckenberger M; Palma DA
    Radiother Oncol; 2020 Jun; 147():231. PubMed ID: 32389757
    [No Abstract]   [Full Text] [Related]  

  • 33. Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic.
    Milanese G; Sabia F; Sestini S; Ledda RE; Rolli L; Suatoni P; Sverzellati N; Sozzi G; Apolone G; Marchianò AV; Pastorino U
    Chest; 2021 Jul; 160(1):e5-e7. PubMed ID: 33745992
    [No Abstract]   [Full Text] [Related]  

  • 34. Lung Cancer Screening Rates During the COVID-19 Pandemic.
    Fedewa SA; Bandi P; Smith RA; Silvestri GA; Jemal A
    Chest; 2022 Feb; 161(2):586-589. PubMed ID: 34298006
    [No Abstract]   [Full Text] [Related]  

  • 35. Colorectal cancer screening and the COVID-19 pandemic - Lessons learnt.
    Halloran SP
    Prev Med; 2021 Oct; 151():106539. PubMed ID: 34217407
    [No Abstract]   [Full Text] [Related]  

  • 36. Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic.
    Blais N; Bouchard M; Chinas M; Lizotte H; Morneau M; Spicer J; Martel S
    Curr Oncol; 2020 Jun; 27(3):e313-e317. PubMed ID: 32669938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of coronavirus disease 2019 on the practice of thoracic oncology surgery: a survey of members of the European Society of Thoracic Surgeons (ESTS).
    Depypere LP; Daddi N; Gooseman MR; Batirel HF; Brunelli A
    Eur J Cardiothorac Surg; 2020 Oct; 58(4):752-762. PubMed ID: 32862224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the Impact of Delaying the Diagnosis of Non-Small Cell Lung Cancer During COVID-19.
    Shipe ME; Haddad DN; Deppen SA; Kozower BD; Grogan EL
    Ann Thorac Surg; 2021 Jul; 112(1):248-254. PubMed ID: 33091367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19, Cancer Care and Prevention.
    DuBois RN
    Cancer Prev Res (Phila); 2020 Nov; 13(11):889-892. PubMed ID: 32958589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.
    Chang HL; Wei PJ; Wu KL; Huang HL; Yang CJ
    Lung Cancer; 2020 Aug; 146():376-377. PubMed ID: 32576385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.